Covered recipient · General Payments record
ANTHONY J BRUNE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$18,215.98
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $357.90 | 25 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $143.47 | 14 |
| UCB, Inc. | $41.07 | 2 |
| Biogen, Inc. | $37.24 | 2 |
| Lilly USA, LLC | $34.72 | 2 |
| Merz Pharmaceuticals, LLC | $26.72 | 1 |
| ARGENX US, INC. | $23.15 | 1 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.30 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.05 | 1 |
| Averitas Pharma Inc. | $14.18 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $11.00 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381927 | CMS |
| ABBVIE INC. | $1.28 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381929 | CMS |
| ABBVIE INC. | $8.13 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381931 | CMS |
| ABBVIE INC. | $5.03 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381933 | CMS |
| ABBVIE INC. | $4.36 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381935 | CMS |
| ABBVIE INC. | $5.67 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381937 | CMS |
| ABBVIE INC. | $1.86 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381939 | CMS |
| ABBVIE INC. | $7.98 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381941 | CMS |
| ABBVIE INC. | $8.73 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381943 | CMS |
| ABBVIE INC. | $28.38 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381945 | CMS |
| ABBVIE INC. | $7.03 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381947 | CMS |
| ABBVIE INC. | $11.72 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381949 | CMS |
| ABBVIE INC. | $23.63 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381951 | CMS |
| ABBVIE INC. | $18.67 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103381953 | CMS |
| ARGENX US, INC. | $23.15 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142120397 | CMS |
| Averitas Pharma Inc. | $14.18 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133419728 | CMS |
| Biogen, Inc. | $19.94 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104866046 | CMS |
| Biogen, Inc. | $17.30 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104861520 | CMS |
| Lilly USA, LLC | $17.73 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136044036 | CMS |
| Lilly USA, LLC | $16.99 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136047569 | CMS |
| Merz Pharmaceuticals, LLC | $26.72 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137946775 | CMS |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $20.30 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144512865 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.05 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151714401 | CMS |
| UCB, Inc. | $21.69 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143038603 | CMS |
| UCB, Inc. | $19.38 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143038605 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.